Innomar Strategies
Vishal Oza is a Regulatory Affairs Manager with extensive experience in the pharmaceutical industry, currently working at Innomar Strategies since January 2023. Key responsibilities include serving as the primary contact for clients on US submissions, developing regulatory assessments and filing strategies, consulting with the FDA, and handling orphan drug designation requests. Prior to this role, Vishal worked at Amneal Pharmaceuticals, focusing on inhalation dosage forms and regulatory assessments, and at SUN PHARMA, where responsibilities included managing regulatory projects for complex dosage forms and supporting drug product approvals. Early career roles included regulatory affairs positions at Mylan Laboratories Limited and Alembic Pharmaceuticals Limited, as well as analytical development at Zydus Cadila. Vishal holds an M.Pharmacy in Pharmaceutical Analysis and Quality Assurance from Nirma Institute of Pharmacy and a certification as a Personal Trainer from the International Sports Sciences Association.
This person is not in any offices
Innomar Strategies
2 followers
Innomar Strategies, a part of AmerisourceBergen, is the leading patient support provider in the Canadian specialty biopharmaceutical market. We deliver end-to-end commercialization solutions to improve product access, increase supply chain efficiency and enhance patient care. Strategic consulting, patient support programs, nursing and clinical services, and specialty pharmacy and logistics are just a few of our key areas of specialization. We partner closely with manufacturers, healthcare providers, pharmacies and payers to ensure patients have consistent and reliable access to specialty medication. With our integrated approach and commitment to best-in-class care, Innomar Strategies helps navigate the patient journey to optimize health outcomes.